In a recent study published in JAMA Internal Medicine, researchers found for individuals with diabetes, statin initiation is linked to diabetes progression.
The study is from the VA North Texas Health Care System. One author is Ishak A. Mansi, M.D.
In the study, the team examined diabetes progression after statin initiation among patients with diabetes.
Data were obtained from patients aged 30 years or older who initiated treatment with statins (statin users) or with H2-blockers or proton pump inhibitors (active comparators); 83,022 pairs of statin users and active comparators were tested
The researchers found that the diabetes progression outcome (new insulin initiation, increase in the number of glucose-lowering medication classes, the incidence of five or more measurements of blood glucose of 200 mg/dL or greater, or a new diagnosis of ketoacidosis or uncontrolled diabetes) occurred in 55.9% and 48.0% of statin users and active comparators, respectively.
Among statin users, each individual component of the composite outcome was much higher.
In a secondary analysis, the team found a dose-response link, with a higher intensity of low-density lipoprotein cholesterol-lowering linked to a greater progression of diabetes.
The researchers suggest that further research is needed to form a risk-tailored approach to balancing the cardiovascular benefits of statin therapy with its risk of diabetes progression.
If you care about type 2 diabetes, please read studies about older men with this health condition are more likely to develop diabetes and findings of a better way to control blood sugar in diabetes.
For more information about diabetes treatment and prevention, please see recent studies about this tree seed may help treat diabetes, obesity and results showing how to lower side effects of once-popular diabetes drug.
Copyright © 2021 Knowridge Science Report. All rights reserved.
